(For treatment side effects and complications only)
Capecitabine & Oxaliplatin 21 Day Cycle (CAPOX) Protocol V4.0
Cetuximab & FOLFIRI Protocol V1.1
Cetuximab & FOLFOX Protocol V1.2
Encorafenib and Cetuximab Metastatic Colorectal Cancer Protocol V1.1
Entrectinib - NTRK Gene Fusion-positive Solid Tumours ROS1-positive NSCLC Protocol V1.1
FOLFIRI Protocol V1.1
FOLFOX Protocol V1.2
Irinotecan & Capecitabine (14 day regimen) (I-Cap) Protocol V1.1
irinotecan single agent 2 weekly or 3 weekly protocol
Larotrectinib NTRK Gene Fusion-positive Solid Tumours Protocol V1.0
Mitomycin C & Capecitabine (MMC Capecitabine) Protocol V1.1
Mitomycin-C 5FU & Folinic Acid (MMC+MdG) Protocol V1.0
Modified De Gramont Protocol V1.0
Nivolumab Metastatic Colorectal Cancer Compassionate Use Protocol V1.0
Nivolumab with Ipilimumb Metastatic Colorectal Cancer (mCRC) Protocol V1.0
Oxaliplatin & Capecitabine (Ox-Cap) Protocol V1.1
Panitumumab & FOLFIRI Protocol V2.1
Panitumumab & FOLFOX Colorectal Cancer V2.0
Pembrolizumab Metastatic Colorectal Cancer Protocol V1.0
Raltitrexed & Oxaliplatin (TOMOX) Protocol V1.0
Regorafenib Colorectal V1.0